🇺🇸 FDA
Patent

US 10688080

Compositions, methods of use, and methods of treatment

granted A61KA61K31/41A61K31/4155

Quick answer

US patent 10688080 (Compositions, methods of use, and methods of treatment) held by The Regents of the University of California expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/41, A61K31/4155, A61K31/427, A61K31/454